Medical Xpress: Radiology
APRIL 2, 2024
The world's most powerful MRI scanner has delivered its first images of human brains, reaching a new level of precision that is hoped will shed more light on our mysterious minds—and the illnesses that haunt them.
Imaging Technology
APRIL 2, 2024
milla1cf Tue, 04/02/2024 - 18:41 April 2, 2024 — iCAD, Inc. , a global leader in clinically proven AI -powered cancer detection solutions, announced commercial availability of ProFound Cloud. The innovative Software-as-a-Service (SaaS) platform provides medical providers with a cost-effective, secure, and scalable means to access and deploy the latest ProFound Breast Health Suite of AI solutions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MRI Network
APRIL 2, 2024
The global healthcare sector is undergoing a period of unprecedented transformation, driven by technological advancements, demographic shifts, and evolving patient needs. Among the chief concerns is the looming shortfall in healthcare workers. This is a trend that MRI Network recruiters who specialize in healthcare have been addressing even before the need became so acute, filling more than a thousand positions over the past two years.
Imaging Technology
APRIL 2, 2024
milla1cf Tue, 04/02/2024 - 18:51 April 2, 2024 — Less than three months after signing an agreement to acquire MIM Software Inc. , GE HealthCare Technologies Inc. announced the acquisition’s close and addition of MIM Software’s imaging analytics and digital workflow solutions as a part of its leading global medical technology, pharmaceutical diagnostics, and digital portfolio.
Advertisement
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
Diagnostic Imaging
APRIL 2, 2024
Researchers noted a 67.4 percent increase in head and neck CT angiography and a 38 percent reduction in findings of acute pathology in a recent comparison of 2017 and 2021 statistics for headache and/or dizziness presentations at the emergency department of an urban academic medical center.
Diagnostic Imaging Brief brings together the best content for architecture professionals from the widest variety of industry thought leaders.
Diagnostic Imaging
APRIL 2, 2024
Up to 48 percent of unnecessary prostate biopsies could be eliminated by limiting biopsy to patients with PI-RADS 4 and higher MRI assessments and a prostate-specific antigen density level below 0.15 ng/mL2, according to a new meta-analysis.
Medical Xpress: Radiology
APRIL 2, 2024
In a 10-center study, microwave ablation offered progression-free survival rates and fewer complications than surgery in the treatment of a form of thyroid cancer known as papillary thyroid carcinoma (PTC), according to research published in Radiology.
Health IT Analytics
APRIL 2, 2024
New machine learning tool uses data on individualized molecular interactions to predict how a patient’s immune system will respond to foreign cells.
Medical Xpress: Radiology
APRIL 2, 2024
Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers?
MRI Network
APRIL 2, 2024
In most industries, you either occupy the supply side or the demand side of the equation. Recruiters don’t. We’re the tip of the spear on two sides and equally responsible to the hiring authorities and the talent. Fail to keep both sides sharp and focus too heavily on one side? We won’t be able to efficiently and predictably connect talented individuals to great organizations.
MedImaging Radiography
APRIL 2, 2024
Researchers are developing and clinically testing MRI and PET technologies that can noninvasively examine and quantify immune cells present in tumors.
UCSF Biomedical Imaging
APRIL 2, 2024
Hyperpolarized MRI Technology Resource Center highlight new methods to better image cancer in the kidney, brain, and pancreas.
JVIR
APRIL 2, 2024
n-Butyl-2-cyanoacrylate (nBCA), frequently used as a neurointerventional embolic agent, has also been proven useful in peripheral applications (1,2). However, specific training and extensive experience are required because of the complexities associated with its dilution, delivery, and prevention of nontarget embolization (1). This report describes a case of unexpected delayed nBCA backflow during catheter withdrawal after pseudoaneurysm embolization.
Expert insights. Personalized for you.
142 
Let's personalize your content